Federal Circuit Bars Review of Inter Partes Review Denials

Note: This article is for general informational and SEO publishing purposes only. It discusses patent-law developments in standard American English and should not be treated as legal advice.

Introduction: The Courthouse Door Gets a Very Firm “Closed” Sign

In U.S. patent litigation, few procedural tools have been as powerfulor as controversialas inter partes review, better known as IPR. Created by the America Invents Act, IPR lets a third party ask the Patent Trial and Appeal Board, or PTAB, to reconsider whether issued patent claims should have been granted in the first place. For companies facing patent infringement lawsuits, IPR can be the legal equivalent of calling in a second referee. For patent owners, it can feel like winning the big game and then being told there is still one more video review.

But recent Federal Circuit decisions have made one point especially clear: when the U.S. Patent and Trademark Office denies institution of an IPR, the disappointed petitioner usually cannot run to the Federal Circuit for rescue. The statutory phrase doing most of the heavy lifting is found in 35 U.S.C. § 314(d), which says the Director’s determination whether to institute inter partes review is “final and nonappealable.” That sentence is short, but in patent practice it lands with the force of a closing garage door.

The Federal Circuit’s latest mandamus rulings reinforce a long-running theme in IPR law: institution decisions belong mostly to the USPTO Director’s discretion. Petitioners may dislike the agency’s reasoning. They may think the policy changed too quickly. They may believe a discretionary denial undermines the purpose of IPR. Still, unless they can show a narrow, colorable constitutional problem or another exceptional basis for relief, the court is likely to say: this is not reviewable.

What Is Inter Partes Review?

Inter partes review is a post-grant proceeding used to challenge the patentability of one or more claims in an issued U.S. patent. It is limited to anticipation and obviousness grounds under Sections 102 and 103, and it must rely on patents or printed publications. In plain English, an IPR petitioner generally argues, “This invention was already known or would have been obvious based on earlier written materials.” It is not a free-for-all challenge involving every possible patent defect.

The PTAB may institute an IPR only if the petition shows a reasonable likelihood that the petitioner would prevail on at least one challenged claim. If instituted, the case moves into a trial-like administrative proceeding with briefing, expert declarations, oral argument, and a final written decision. If not instituted, the petition stops at the gate. No trial. No final written decision. No confetti cannon for the petitioner.

Why IPR Became So Important

IPR became popular because it can be faster and more technically focused than district court litigation. A patent defendant sued for infringement may file an IPR petition and then ask the district court to stay the lawsuit while the PTAB evaluates patentability. If the PTAB cancels key claims, the lawsuit may shrink or disappear. That is why IPR has often been viewed as a central defense strategy in technology, pharmaceutical, medical device, semiconductor, and software patent disputes.

Patent owners, however, have long argued that repeated or late-filed IPR petitions can create unfair pressure, increase costs, and undermine settled expectations in issued patent rights. The USPTO’s discretionary denial framework reflects these concerns. It allows the agency to consider whether review would be efficient, fair, and consistent with the agency’s workload and institutional goals.

The Statutory Wall: 35 U.S.C. § 314(d)

The core legal issue is deceptively simple. Section 314(d) states that the Director’s determination whether to institute IPR “shall be final and nonappealable.” That language does not merely discourage appeals; it largely bars them. The Supreme Court has repeatedly interpreted this provision to shield institution decisions from ordinary judicial review, especially when the challenge is closely tied to the agency’s institution analysis.

In Cuozzo Speed Technologies v. Lee, the Supreme Court held that Section 314(d) bars judicial review of ordinary challenges to the USPTO’s decision to institute IPR. Later, in Thryv v. Click-to-Call Technologies, the Court extended that logic to timing-related institution disputes, holding that even certain statutory preconditions tied to institution fall within the no-appeal zone. Meanwhile, SAS Institute v. Iancu confirmed that the Director has discretion over whether to institute review, even though once review is instituted, the PTAB must address all claims challenged by the petitioner.

Together, these decisions create a practical rule: courts may review final written decisions on patentability, but they usually may not review the agency’s threshold decision to startor not startthe IPR. It is a bit like being able to appeal the final score of a game only if the game was actually played.

The Federal Circuit’s Recent Message: Mandamus Is Not a Shortcut

Because ordinary appeal is barred, disappointed petitioners have tried another route: mandamus. A writ of mandamus is an extraordinary remedy that asks an appellate court to order a government actor or lower tribunal to perform a duty. It is not a casual “please reconsider” button. Courts describe mandamus as drastic relief reserved for exceptional situations.

To win mandamus, a petitioner must usually show a clear and indisputable right to relief, no adequate alternative means to obtain that relief, and circumstances making the writ appropriate. That is a tall order in any case. In IPR institution disputes, it is taller than a stack of patent claim charts printed in 8-point font.

In recent cases involving companies such as Motorola Solutions, SAP America, Google, Cambridge Industries, SanDisk, Western Digital, and HighLevel, petitioners argued that the USPTO’s discretionary denial policies were unlawful, unfairly retroactive, inadequately explained, or inconsistent with the America Invents Act. The Federal Circuit repeatedly rejected mandamus relief, emphasizing that Section 314(d) makes institution decisions final and nonappealable and that mandamus is ordinarily unavailable to review those decisions.

Motorola: The Precedential Anchor

The Federal Circuit’s decision in In re Motorola Solutions is especially important because it was precedential and provided the framework for later denials. Motorola’s IPRs had initially been instituted, but the Acting Director later vacated institution after a shift in USPTO guidance concerning discretionary denial and parallel litigation. Motorola argued that this reversal violated the Administrative Procedure Act and due process.

The Federal Circuit denied relief. It explained that Congress committed institution decisions to the Director’s discretion and protected that discretion from judicial review. The court acknowledged that colorable constitutional claims might sometimes escape the review bar, but it concluded that Motorola had not shown a protected property interest in having its IPRs proceed. The court also rejected the argument that APA challenges could be used as an end run around Section 314(d).

That phrase“end run”captures the court’s mood. The Federal Circuit was not interested in letting petitioners repackage institution challenges as due process, arbitrary-and-capricious, or rulemaking claims when the real goal was to undo a specific denial of IPR institution.

Cambridge, SanDisk, and the “Settled Expectations” Factor

After Motorola, the Federal Circuit considered challenges involving the USPTO’s use of “settled expectations.” This factor looks at whether a patent has been in force long enough that the patent owner may have developed reliance interests in the patent’s validity. Petitioners argued that the USPTO had no statutory authority to deny IPR based on patent age or settled expectations. Patent owners, unsurprisingly, saw the factor as a useful shield against late-stage administrative attacks.

In In re Cambridge Industries, the petitioner challenged denials involving older patents, arguing that the Director’s reliance on settled expectations exceeded statutory authority and violated due process. The Federal Circuit denied mandamus. Importantly, the court did not decide whether the USPTO’s use of settled expectations was substantively correct. Instead, it held that Cambridge failed to show a clear and indisputable right to relief given the limits on judicial review.

That distinction matters. The Federal Circuit did not necessarily bless every aspect of the USPTO’s discretionary denial policy. It simply said the petitioner had not found a reviewable path through the statutory wall. For practitioners, that is a frustrating but crucial difference. The court’s answer was not “the agency is definitely right.” It was closer to “even if you think the agency is wrong, this is probably not the vehicle.”

Apple v. Vidal and the Narrow APA Opening

There is one important nuance: the Federal Circuit has recognized that some broad challenges to USPTO rules or policies may be brought outside the context of reviewing a specific institution decision. In Apple v. Vidal, the court held that certain challenges to the Director’s instructions concerning discretionary denial were unreviewable to the extent they attacked individual institution discretion. However, the court allowed a notice-and-comment rulemaking challenge to proceed because it was framed apart from review of a particular institution decision.

This creates a narrow opening. A party may be able to bring an APA challenge in district court arguing that the USPTO adopted a generally applicable policy without required procedure. But if the requested relief is essentially “reinstate my denied IPR,” the Federal Circuit is likely to see the challenge as barred by Section 314(d). In patent-law terms, the claim scope of reviewability is narrow, and the Federal Circuit is reading it with a very careful eye.

Why the Federal Circuit’s Approach Matters

The Federal Circuit’s decisions affect both sides of patent litigation. For patent challengers, the message is sobering: an IPR petition is not a guaranteed ticket to PTAB review. Even a strong invalidity argument may never reach the merits if the Director or PTAB discretionarily denies institution. Companies must therefore treat the institution stage as a high-stakes moment, not a warm-up act.

For patent owners, the decisions strengthen the value of discretionary denial arguments. A patent owner facing an IPR petition should consider whether parallel litigation, prior adjudications, serial petitions, timing, resources, patent age, or settled expectations support denial. If the USPTO agrees, the petitioner may have very limited appellate recourse.

For the broader patent system, the rulings raise a policy debate. Supporters say unreviewability preserves agency efficiency and respects Congress’s design. Critics argue that broad discretion without meaningful review can produce unpredictability and reduce access to a key patent-quality tool. Both sides have a point. The AIA created IPR to improve patent quality, but it also gave the USPTO a gatekeeping role. The fight is over how heavy that gate should beand who gets to check whether it is being closed properly.

Strategic Lessons for Petitioners

File Early and Think Beyond the Merits

Petitioners should not assume that strong prior art alone will carry the day. The institution decision may turn on timing, parallel litigation status, stipulations, workload concerns, or discretionary considerations. Filing earlier in the litigation timeline may reduce the risk that a district court schedule weighs against institution.

Use Stipulations Carefully

Sotera-style stipulations, in which petitioners agree not to pursue overlapping invalidity grounds in district court, have historically helped reduce discretionary denial risk. But recent policy changes show that stipulations may not always function as a safe harbor. Petitioners should draft them carefully and understand that the USPTO may still find institution inefficient.

Preserve Alternative Defenses

Because an IPR denial may be unreviewable, defendants should avoid putting all invalidity eggs in the PTAB basket. District court defenses, ex parte reexamination, licensing strategy, claim construction, noninfringement positions, and settlement planning may all remain important. Patent litigation is chess, not checkersand sometimes the PTAB square is unavailable.

Strategic Lessons for Patent Owners

Build a Discretionary Denial Record

Patent owners should treat the preliminary response as more than a merits brief. It is an opportunity to show why institution would be inefficient, duplicative, unfair, or inconsistent with agency policy. A well-developed discretionary denial argument may prevent the IPR from ever reaching trial.

Emphasize Parallel Proceedings

If a district court or International Trade Commission case is moving quickly, patent owners should highlight completed claim construction, discovery progress, trial dates, overlapping issues, and investment by the parties. The more advanced the parallel case, the stronger the argument that PTAB review would duplicate effort.

Use Settled Expectations Thoughtfully

For older patents, patent owners may argue that years of enforcement, licensing, investment, or industry reliance support settled expectations. This argument is not magic dust, but in the current environment it may be meaningful. Like good coffee and clear claim language, it should not be underestimated.

Specific Example: The Older Patent Problem

Imagine a patent issued nine years ago. The owner has licensed it, invested in related products, and enforced it in litigation. A defendant files an IPR after being sued. The petition includes strong prior-art arguments, but the USPTO sees the patent’s age, the owner’s reliance, and the parallel court case as reasons to deny institution. The petitioner then asks the Federal Circuit for mandamus, arguing that “settled expectations” is not a valid statutory basis for denial.

Under the recent Federal Circuit approach, the petitioner faces a difficult path. The court may say that the argument challenges the Director’s institution discretion and is therefore insulated by Section 314(d). Unless the petitioner can identify a truly colorable constitutional claim or a reviewable challenge independent of the specific institution denial, the petition likely fails. The patent may still be challenged in district court, but the PTAB door stays closed.

Experience-Based Analysis: What This Feels Like in Real Patent Strategy

For lawyers and companies working in patent disputes, the Federal Circuit’s bar on reviewing IPR denials changes the rhythm of litigation planning. In earlier years, many defendants treated IPR as an expected part of the defense playbook. Receive complaint, analyze asserted claims, search prior art, file IPR, request stay. It was never automatic, but it became familiar enough that some teams built budgets and timelines around it. Recent discretionary denial practice makes that routine less comfortable.

The first practical experience is uncertainty. A petitioner may spend hundreds of hours and significant expert resources preparing a strong IPR petition, only to have the petition denied for reasons unrelated to whether the prior art is persuasive. That can be deeply frustrating. It is like preparing a brilliant trial presentation and then being told the courtroom is unavailable because another meeting is already using the projector. The merits may be excellent, but the procedure controls the outcome.

The second experience is timing pressure. Defense teams now need to evaluate IPR strategy almost immediately after a complaint is filed. Waiting too long can make parallel litigation more advanced, which can support discretionary denial. Counsel must coordinate prior-art searching, expert review, claim mapping, and district court strategy quickly. This creates a premium on early case assessment. The best teams will not wait until the one-year statutory deadline is looming; by then, the discretionary-denial train may have already left the station, and it does not circle back just because your expert declaration looks beautiful.

The third experience is the need for parallel planning. A company can no longer assume that the PTAB will decide patentability. If the IPR is denied and that denial is effectively unreviewable, the defendant must be ready to litigate invalidity in district court. That means preserving prior-art defenses, developing noninfringement arguments, considering claim construction pressure points, and evaluating settlement leverage before the PTAB decision arrives. The IPR petition should be one branch of the strategy tree, not the whole tree.

Patent owners experience the shift differently. For them, discretionary denial can create leverage. If an IPR is denied, the patent owner avoids an expensive PTAB trial and may proceed in district court with momentum. But patent owners should not become overconfident. A denial of IPR is not a ruling that the patent is valid. It only means the agency declined to institute review. District courts can still evaluate invalidity, and juries may still hear prior-art arguments. The win is procedural, not necessarily substantive.

Another real-world effect is settlement posture. When an IPR is instituted, defendants often gain leverage because the asserted claims face cancellation risk. When institution is denied and the denial cannot realistically be appealed, the patent owner’s bargaining position may improve. The litigation becomes less about waiting for the PTAB and more about district court schedules, damages exposure, injunction risk, and claim construction. In other words, the chessboard changes shape.

The most important lesson is that IPR strategy now requires humility. The strongest prior art does not guarantee institution. The cleverest mandamus petition does not guarantee review. The Federal Circuit has made clear that Section 314(d) is not decorative statutory wallpaper; it is a serious jurisdictional barrier. Practitioners who understand that barrier will plan better, advise clients more realistically, and avoid treating mandamus as a dependable escape hatch.

Conclusion: Final and Nonappealable Means What It Says

The Federal Circuit’s recent IPR denial decisions confirm a powerful principle in modern patent law: the USPTO’s decision not to institute inter partes review is usually beyond appellate review. Section 314(d) gives the Director broad discretion, and mandamus will rarely overcome that statutory bar. While APA challenges and constitutional claims may survive in narrow circumstances, petitioners should not expect the Federal Circuit to second-guess ordinary discretionary denials.

For petitioners, the takeaway is clear: file early, build a record that addresses discretionary factors, and prepare district court defenses as if IPR may never happen. For patent owners, the lesson is equally clear: discretionary denial arguments can be case-shaping tools, especially when parallel litigation, patent age, reliance interests, or efficiency concerns are present. The PTAB remains a major patent battleground, but the institution gate is guarded more closely than ever.